Modulation of the humoral response to dermatophagoides pteronyssinus allergens in BALB/c mice by extract modification and adjuvant use

International Archives of Allergy and Immunology

Volumn 157, Issue 4, 2012, Pages 331-338

  Pico De Coaña, Yago ^a   Carnés, Jerónimo ^b   Gallego, Maria T ^b   Alonso, Carlos ^a   Parody, Nuria ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Laboratorios Leti SL   (Spain)

Author keywords

Allergen specific immunotherapy; CpG oligodeoxinucleotide; Depigmented allergoid; House dust mite

Indexed keywords

ALUMINUM HYDROXIDE; CPG OLIGODEOXYNUCLEOTIDE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CROSS REACTION; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; HUMORAL IMMUNITY; IMMUNOBLOTTING; IMMUNOMODULATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; BINDING, COMPETITIVE; CELL EXTRACTS; CROSS REACTIONS; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION, IMMUNOLOGIC; HYPERSENSITIVITY; IMMUNITY, HUMORAL; IMMUNOGLOBULINS; IMMUNOMODULATION; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; PIGMENTS, BIOLOGICAL; POLYMERIZATION;

EID: 82055200576     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000329636     Document Type: Article

References (40)

1. Bousquet J, Lockey R, Malling HJ: Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102: 558-562.
2. Maasch HJ, Marsh DG: Standardized extracts modified allergens -allergoids. Clin Rev Allergy 1987; 5: 89-106.
3. Frew AJ: Allergen immunotherapy. J Allergy Clin Immunol 2010; 125:S306-S313.
4. Carnes J, Himly M, Gallego M, Iraola V, Robinson DS, Fernandez-Caldas E, Briza P: Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba . Clin Exp Allergy 2009; 39: 426-434.
5. Casanovas M, Gomez MJ, Carnes J, Fernandez-Caldas E: Skin tests with native, depigmented and glutaraldehyde polymerized allergen extracts. J Investig Allergol Clin Immunol 2005; 15: 30-36. (Pubitemid 40547629)
6. Casanovas M, Fernandez-Caldas E, Alamar R, Basomba A: Comparative study of tolerance between unmodified and high doses of chemically modified allergen vaccines of Dermatophagoides pteronyssinus . Int Arch Allergy Immunol 2005; 137: 211-218. (Pubitemid 41202760)
7. Casanovas M, Martin R, Jimenez C, Caballero R, Fernandez-Caldas E: Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts. Clin Exp Allergy 2007; 37: 434-440. (Pubitemid 46394433)
8. Sager A, Renner B: Safety aspects and course of allergen-specific immunotherapy with a depigmented, polymerized allergen extract. Allergo J 2004; 13: 386-391. (Pubitemid 39310779)
9. Ameal A, Vega-Chicote JM, Fernandez S, Miranda A, Carmona MJ, Rondon MC, Reina E, Garcia-Gonzalez JJ: Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma. Allergy 2005; 60: 1178-1183. (Pubitemid 41153147)
10. Gallego MT, Iraola V, Himly M, Robinson DS, Badiola C, Garcia-Robaina JC, Briza P, Carnes J: Depigmented and polymerised house dust mite allergoid: Allergen content, induction of IgG4 and clinical response. Int Arch Allergy Immunol 2010; 153: 61-69.
11. Garcia-Robaina JC, Sanchez I, de la Torre F, Fernandez-Caldas E, Casanovas M: Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study. J Allergy Clin Immunol 2006; 118: 1026-1032. (Pubitemid 44666986)
12. Ferrer A, Garcia-Selles J: Significant improvement in symptoms, skin test, and specific bronchial reactivity after 6 months of treatment with a depigmented, polymerized extract of Dermatophagoides pteronyssinus and D. farinae. J Investig Allergol Clin Immunol 2003; 13: 244-251. (Pubitemid 38160367)
13. Marrack P, McKee AS, Munks MW: Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 2009; 9: 287-293.
14. Steinhagen F, Kinjo T, Bode C, Klinman DM: TLR-based immune adjuvants. Vaccine 2010; 29: 3341-3355.
15. Hussain I, Jain VV, Kitagaki K, Businga TR, O'Shaughnessy P, Kline JN: Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides. Laryngoscope 2002; 112: 1819-1826.
16. Jain VV, Kitagaki K, Kline JN: CpG DNA and immunotherapy of allergic airway diseases. Clin Exp Allergy 2003; 33: 1330-1335. (Pubitemid 37289926)
17. Mo JH, Park SW, Rhee CS, Takabayashi K, Lee SS, Quan SH, Kim IS, Min IY, Raz E, Lee CH: Suppression of allergic response by CpG motif oligodeoxynucleotide-housedust mite conjugate in animal model of allergic rhinitis. Am J Rhinol 2006; 20: 212-218.
18. Hirose I, Tanaka H, Takahashi G, Wakahara K, Tamari M, Sakamoto T, Kojima S, Inagaki N, Nagai H: Immunomodulatory effects of CpG oligodeoxynucleotides on house dust mite-induced airway inflammation in mice. Int Arch Allergy Immunol 2008; 147: 6-16.
19. Kaburaki Y, Fujimura T, Kurata K, Masuda K, Toda M, Yasueda H, Chida K, Kawarai S, Sakaguchi M: Induction of Th1 immune responses to Japanese cedar pollen allergen (Cry j 1) in mice immunized with Cry j 1 conjugated with CpG oligodeoxynucleotide. Comp Immunol Microbiol Infect Dis 2011;34:157-161.
20. Brimnes J, Kildsgaard J, Jacobi H, Lund K: Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis. Clin Exp Allergy 2007; 37: 488-497. (Pubitemid 46537734)
21. Hisbergues M, Magi M, Rigaux P, Steuve J, Garcia L, Goudercourt D, Pot B, Pestel J, Jacquet A: In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria. Clin Exp Allergy 2007; 37: 1286-1295. (Pubitemid 47372298)
22. Vrtala S, Ball T, Spitzauer S, Pandjaitan B, Suphioglu C, Knox B, Sperr WR, Valent P, Kraft D, Valenta R: Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J Immunol 1998; 160: 6137-6144. (Pubitemid 28298078)
23. Kim SW, Yeo SW: The effect of bacillus Calmette-Guerin in a mouse model of allergic rhinitis. Otolaryngol Head Neck Surg 2007; 136: 720-725. (Pubitemid 46660219)
24. KleinJan A, Willart M, van Rijt LS, Braunstahl GJ, Leman K, Jung S, Hoogsteden HC, Lambrecht BN: An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol 2006; 118: 1117-1125. (Pubitemid 44666974)
25. On the Protection of Animals Used for Experimentation and Other Scientific Purposes. Boe, 2005. Royal decree 1201/2005, October 10th, Boletín Oficial del Estado, 2005, vol 252, pp 34367-34391.
26. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM: CpG motifs in bacterial DNA trigger direct b-cell activation. Nature 1995; 374: 546-549.
27. Hartmann G, Krieg AM: Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 2000; 164: 944-953.
28. Fernández-Caldas E, Gallego M, Carnes J, Iraola V: Enzymatic activity of Dermatophagoides pteronyssinus extracts after acidic treatment. Int Arch Allergy Immunol 2008; 145: 298-304. (Pubitemid 351416711)
29. Heit A, Busch DH, Wagner H, Schmitz F: Vaccine protocols for enhanced immunogenicity of exogenous antigens. Int J Med Microbiol 2008; 298: 27-32. (Pubitemid 350216558)
30. Kawano Y, Noma T, Yata J: Regulation of human IgG subclass production by cytokines. IFN-β and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol 1994; 153: 4948-4958. (Pubitemid 24356126)
31. Vitetta ES, Ohara J, Myers CD, Layton JE, Krammer PH, Paul WE: Serological, biochemical, and functional identity of B cellstimulatory factor 1 and B cell differentiation factor for IgG1. J Exp Med 1985; 162: 1726-1731. (Pubitemid 16195372)
32. Brewer JM, Conacher M, Hunter CA, Mohrs M, Brombacher F, Alexander J: Aluminium hydroxide adjuvant initiates strong antigenspecific Th2 responses in the absence of IL-4-or IL-13-mediated signaling. J Immunol 1999; 163: 6448-6454.
33. Akdis CA, Blaser K: Mechanisms of allergen-specific immunotherapy. Allergy 2000; 55: 522-530. (Pubitemid 30322198)
34. Fernández-Caldas E, Iraola V, Boquete M, Nieto A, Casanovas M: Mite immunotherapy. Curr Allergy Asthma Rep 2006; 6: 413-419. (Pubitemid 44340174)
35. Ibero M, Castillo MJ: Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of Dermatophagoides pteronyssinus . J Investig Allergol Clin Immunol 2006; 16: 194-202.
36. Hewitt CR, Brown AP, Hart BJ, Pritchard DI: A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J Exp Med 1995; 182: 1537-1544.
37. Schulz O, Laing P, Sewell HF, Shakib F: Der p I, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23). Eur J Immunol 1995; 25: 3191-3194.
38. Schulz O, Sewell HF, Shakib F: Proteolytic cleavage of CD25, the subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J Exp Med 1998; 187: 271-275. (Pubitemid 28060444)
39. Shakib F, Schulz O, Sewell H: A mite subversive: cleavage of CD23 and CD25 by Der p 1 enhances allergenicity. Immunol Today 1998; 19: 313-316. (Pubitemid 28322327)
40. Chapman MD, Wunschmann S, Pomes A: Proteases as Th2 adjuvants. Curr Allergy Asthma Rep 2007; 7: 363-367. (Pubitemid 47377325)